|
|
||||||||
ORIGINAL RESEARCH |
From the Office of Analysis, Epidemiology, and Health Promotion, National Center for Health Statistics, Hyattsville, Maryland, and Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Address reprint requests to: Andrea P. MacKay, MSPH, National Center for Health Statistics, 6525 Belcrest Road, Room 790, Hyattsville, MD 20782, E-mail: anm3{at}cdc.gov
Objective: To examine the role of preeclampsia and eclampsia in pregnancy-related mortality.
Methods: We used data from the Centers for Disease Control and Preventions Pregnancy Mortality Surveillance System to examine pregnancy-related deaths from preeclampsia and eclampsia from 1979 to 1992. The pregnancy-related mortality ratio for preeclampsia-eclampsia was defined as the number of deaths from preeclampsia and eclampsia per 100,000 live births. Case-fatality rates for 19881992 were calculated for preeclampsia and eclampsia deaths per 10,000 cases during the delivery hospitalization, using the National Hospital Discharge Survey.
Results: Of 4024 pregnancy-related deaths at 20 weeks or more gestation in 19791992, 790 were due to preeclampsia or eclampsia (1.5 deaths/100,000 live births). Mortality from preeclampsia and eclampsia increased with increasing maternal age. The highest risk of death was at gestational age 2028 weeks and after the first live birth. Black women were 3.1 times more likely to die from preeclampsia or eclampsia as white women. Women who had received no prenatal care had a higher risk of death from preeclampsia or eclampsia than women who had received any level of prenatal care. The overall preeclampsia-eclampsia case-fatality rate was 6.4 per 10,000 cases at delivery, and was twice as high for black women as for white women.
Conclusion: The continuing racial disparity in mortality from preeclampsia and eclampsia emphasizes the need to identify those differences that contribute to excess mortality among black women, and to develop specific interventions to reduce mortality from preeclampsia and eclampsia among all women.
This article has been cited by other articles:
![]() |
I. Craici, S. Wagner, and V. D. Garovic Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 249 - 259. [Abstract] [PDF] |
||||
![]() |
Z. Li, Y. Zhang, J. Ying Ma, A. M. Kapoun, Q. Shao, I. Kerr, A. Lam, G. O'Young, F. Sannajust, P. Stathis, et al. Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of Preeclampsia Hypertension, October 1, 2007; 50(4): 686 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bodnar, J. M. Catov, H. N. Simhan, M. F. Holick, R. W. Powers, and J. M. Roberts Maternal Vitamin D Deficiency Increases the Risk of Preeclampsia J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3517 - 3522. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leanos-Miranda, J. Marquez-Acosta, F. Romero-Arauz, G. M. Cardenas-Mondragon, R. Rivera-Leanos, I. Isordia-Salas, and A. Ulloa-Aguirre Protein:Creatinine Ratio in Random Urine Samples Is a Reliable Marker of Increased 24-Hour Protein Excretion in Hospitalized Women with Hypertensive Disorders of Pregnancy Clin. Chem., September 1, 2007; 53(9): 1623 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Tucker, C. J. Berg, W. M. Callaghan, and J. Hsia The Black-White Disparity in Pregnancy-Related Mortality From 5 Conditions: Differences in Prevalence and Case-Fatality Rates Am J Public Health, February 1, 2007; 97(2): 247 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Euser and M. J. Cipolla Cerebral Blood Flow Autoregulation and Edema Formation During Pregnancy in Anesthetized Rats Hypertension, February 1, 2007; 49(2): 334 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dokras, D. S. Hoffmann, J. S. Eastvold, M. F. Kienzle, L. M. Gruman, P. A. Kirby, R. M. Weiss, and R. L. Davisson Severe Feto-Placental Abnormalities Precede the Onset of Hypertension and Proteinuria in a Mouse Model of Preeclampsia Biol Reprod, December 1, 2006; 75(6): 899 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Tanjung, H. D. Siddik, H. Hariman, and S. C.L. Koh Coagulation and Fibrinolysis in Preeclampsia and Neonates Clinical and Applied Thrombosis/Hemostasis, October 1, 2005; 11(4): 467 - 473. [Abstract] [PDF] |
||||
![]() |
A. H. James, C. D. Bushnell, M. G. Jamison, and E. R. Myers Incidence and Risk Factors for Stroke in Pregnancy and the Puerperium Obstet. Gynecol., September 1, 2005; 106(3): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Sibai Diagnosis, Prevention, and Management of Eclampsia Obstet. Gynecol., February 1, 2005; 105(2): 402 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Callaghan and C. J. Berg Pregnancy-Related Mortality Among Women Aged 35 Years and Older, United States, 1991-1997 Obstet. Gynecol., November 1, 2003; 102(5): 1015 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Polliotti, A. G. Fry, D. N. Saller Jr, R. A. Mooney, C. Cox, and R. K. Miller Second-Trimester Maternal Serum Placental Growth Factor and Vascular Endothelial Growth Factor for Predicting Severe, Early-Onset Preeclampsia Obstet. Gynecol., June 1, 2003; 101(6): 1266 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hernandez-Diaz, M. M. Werler, C. Louik, and A. A. Mitchell Risk of Gestational Hypertension in Relation to Folic Acid Supplementation during Pregnancy Am. J. Epidemiol., November 1, 2002; 156(9): 806 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Gray, P. A. Cooper, B. J. Cory, M. Toman, and N. J. Crowther The Intrauterine Environment Is a Strong Determinant of Glucose Tolerance during the Neonatal Period, Even in Prematurity J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4252 - 4256. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lynch, R. McDuffie Jr, J. Murphy, K. Faber, and M. Orleans Preeclampsia in Multiple Gestation: The Role of Assisted Reproductive Technologies Obstet. Gynecol., March 1, 2002; 99(3): 445 - 451. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |